Page last updated: 2024-09-04

ino 2628-cz and cardiovascular agents

ino 2628-cz has been researched along with cardiovascular agents in 2 studies

Compound Research Comparison

Studies
(ino 2628-cz)
Trials
(ino 2628-cz)
Recent Studies (post-2010)
(ino 2628-cz)
Studies
(cardiovascular agents)
Trials
(cardiovascular agents)
Recent Studies (post-2010) (cardiovascular agents)
80017,6451,4806,891

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barre, J; de Biasi, J; Houin, G; Plusquellec, Y; Tillement, JP; Trenque, T1
Akahane, K; Chiba, S; Furukawa, Y; Ogiwara, Y1

Other Studies

2 other study(ies) available for ino 2628-cz and cardiovascular agents

ArticleYear
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration.
    Journal of pharmaceutical sciences, 1992, Volume: 81, Issue:10

    Topics: Administration, Oral; Adult; Cardiotonic Agents; Cardiovascular Agents; Enterohepatic Circulation; Humans; Infusions, Intravenous; Intestinal Absorption; Male; Models, Biological; Piperazines

1992
Negative chronotropic and positive inotropic effects of a unique cardioactive agent, N,N'-dicyclopropyl methyl piperazine (bis) hydrochloride (INO 2628), in isolated, blood-perfused dog atria.
    Japanese heart journal, 1988, Volume: 29, Issue:6

    Topics: Animals; Cardiovascular Agents; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Heart Atria; Heart Rate; Myocardial Contraction; Piperazines; Sinoatrial Node; Stimulation, Chemical

1988